 Antony Waste Handling Cell Ltd Q2 FY2026 consolidated net profit down QoQ to Rs. 13.65 crores
Antony Waste Handling Cell Ltd Q2 FY2026 consolidated net profit down QoQ to Rs. 13.65 crores Eiko Lifesciences Ltd Q2FY26 consolidated PAT increases to Rs. 1.07 crore
Eiko Lifesciences Ltd Q2FY26 consolidated PAT increases to Rs. 1.07 crore LG Balakrishnan and Bros Ltd Q2 FY2026 consolidated net profit soars to Rs. 93.62 crores
LG Balakrishnan and Bros Ltd Q2 FY2026 consolidated net profit soars to Rs. 93.62 crores Mahindra Holidays and Resorts India Ltd posts higher consolidated PAT of Rs. 17.85 crores in Q2FY26
Mahindra Holidays and Resorts India Ltd posts higher consolidated PAT of Rs. 17.85 crores in Q2FY26 Balkrishna Industries Ltd consolidated Q2FY26 PAT falls to Rs. 273.19 crores
Balkrishna Industries Ltd consolidated Q2FY26 PAT falls to Rs. 273.19 crores 
              Lyka Labs Ltd has announced that an Extra Ordinary General Meeting (EGM) of the members of the Company will be held on November 28, 2006, inter alia, to transact the following:
1. To issue upto 13,00,000 Equity Share Warrants (the Warrant) to the Promoters/Promoter Group of the Company and their nominees, each Warrant entitling the holder thereof to apply for and be allotted one equity share of the Company, of Rs 10/- each, on payment of an exercise price of Rs 41.50 per share, in three stages viz., 3,75,000 Warrants to be converted into Equity Shares on or before March 31, 2007, 2,75,000 Warrants to be converted into Equity Shares on or before March 31, 2008, and 6,50,000 Warrants to be converted into Equity Shares on or before June 12, 2008, in accordance with the Guidelines on Preferential issues dated August 04, 1994, (the SEBI Guidelines) framed under the SEBI (Disclosure and Investor Protection) Guidelines, 2000, (as amended till date) and issued by SEBI, subject to necessary provisions & approvals.
2. To issue upto 1,50,000 Equity Share Warrants (the Warrants) to the Business Associates / Domestic Investors, each Warrant entitling the holder thereof to apply for and be allotted one equity share of Rs 10/- each of the Company on payment of an exercise price of Rs 41.50 per share during such period and in such manner and on such other terms as the Board may in its absolute discretion deem fit subject to the same being in accordance with the Guidelines on Preferential Issues framed under the SEBI (Disclosure and Investor Protection ) Guidelines, 2000, issued by SEBI, subject to necessary provisions & approvals.